Latest stories on BMEA
Biomea Fusion, Inc. (BMEA) Presents at H.C. Wainwright 28th Annual Global Investment Conference - Slideshow
Seeking Alpha50 · neutralgeneral
Biomea Fusion to Participate in Upcoming Investor Conferences
GlobeNewswire56 · neutralgeneral
Biomea Fusion to Participate in Upcoming Investor Conferences
Business Insider56 · neutralgeneral
Biomea Fusion Reaches Enrollment Milestone in Key Phase II Diabetes Trial—What the COVALENT-211 Update Means for Insulin-Deficient T2D Patients
MarketChameleon63 · neutralproduct/pr
Biomea Fusion stock surges on diabetes trial enrollment completion
Investing.com Markets67 · bullishproduct/pr
Biomea Fusion Hits Enrollment Milestone for Icovamenib Phase II Trial in Insulin-Deficient Type 2 Diabetes
August 24, 2026
MarketChameleon67 · bullishproduct/pr
H.C. Wainwright reiterates Biomea Fusion stock rating on trial enrollment
Investing.com Analyst Ratings56 · neutralanalyst
Why is Biomea Fusion stock climbing today?
Investing.com Markets50 · neutralgeneral
Biomea Fusion completes enrollment in COVALENT-211 trial
The Fly59 · neutralproduct/pr
Biomea Fusion doses first patient in OPAL study
The Fly63 · neutralproduct/pr
Biomea Fusion Announces First Patient Dosed in OPAL Study Evaluating Icovamenib in Combination with Semaglutide in Obesity
StockTitan63 · neutralproduct/pr
Citi Adds Upside 90 Day Catalyst Watch On Biomea Into Glp 1 Data
The Fly56 · neutralanalyst
Biomea Fusion price target lowered to $7 from $9 at Citizens
The Fly34 · bearishanalyst
Biomea Fusion GAAP EPS of -$0.12 beats by $0.10
Seeking Alpha56 · neutralearnings
Biomea Fusion, Inc. (BMEA) files 8-K
SEC 8-K50 · neutralgeneral
Biomea Fusion Reports Second Quarter 2026 Financial Results and Corporate Highlights
Business Insider56 · neutralearnings
Biomea Fusion, Inc. (BMEA) files 8-K
SEC 8-K50 · neutralgeneral
Biomea Fusion, Inc. (BMEA) Presents at American Diabetes Association (ADA) 86th Scientific Sessions - Slideshow
Seeking Alpha50 · neutralproduct/pr